Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.

GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Abstract Text:

    ratna prasadRatna Prasad,shailendra giriShailendra Giri,narender nathNarender Nath,inderjit singhInderjit Singh,avtar k singhAvtar K Singh,

    S-Nitrosoglutathione (GSNO) is an endogenous nitric oxide carrier and recently, has been documented for its anti-inflammatory effects in rat model of cerebral ischemia (Khan et al. (2005) J Cereb Blood Flow Metab 25:177-192). Here, we explored the neuroprotective effects mediated by GSNO in Lewis rat model of EAE and its mechanism of action using in vitro model of monocyte-endothelial cell interaction. Oral administration of GSNO attenuated the clinical disease course in EAE animals by inhibiting the infiltration of vascular immune cells in the CNS that subsequently led to the reduction in the expression of proinflammatory cytokines and consequently limited demyelination. Based on the inhibition in infiltration of immune cells, we hypothesized that GSNO modulated endothelial cell activation that led to reduce cellular infiltration in the CNS. Using an in vitro model, we established that GSNO inhibited monocyte adhesion to the activated endothelial cell, which was mediated by down regulation of endothelial cell adhesion molecules (CAMs). The mechanism by which GSNO modulated CAMs expression appeared to be via S-nitrosylation of p65, which consequently inhibited nuclear factor kappa B (NF-kappaB) activation in endothelial cells. These observations suggest that GSNO exerts its protective effects in EAE by inhibition of cellular infiltration into the CNS by S-nitrosylation of p65, thereby modulating NF-kappaB-CAMs pathway in endothelial cells.

    GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Publishing Authors By Initials

    r prasadR Prasad,s giriS Giri,n nathN Nath,i singhI Singh,ak singhAK Singh,

    For similar peptides: intercellular signaling peptides and proteins: cytokines: monokines: tumor necrosis factor-alpha research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: monokines: tumor necrosis factor-alpha research

    PUBMED ID PMID:

    MEDLINE DATE:

    GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Glia

    VOLUME: 55

    Page Numbers: 65-77

    Journal Abbreviation: Glia

    ISSN: 0894-1491

    DAY: 1

    MONTH: Jan

    YEAR: 2007

    GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8806785

    GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Keywords Mesh Terms:

    KEYWORDS: Tumor Necrosis Factor-alpha

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Information

    Substance Name: S-Nitrosoglutathione

    Registry Number: 57564-91-7

    Grant and Affiliation Information for GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.

    AFFILIATION: Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NINDS

    GRANT: NS-40810

    ACRONYM: NS

    MEDLINETA: Glia

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News